Homocysteine-lowering therapy with supplemental B vitamins (folic acid, vitamin B 6 , and vitamin B 12 ) may be particularly useful in lowering the risk of stroke but appears to have little utility in the prevention of other cardiovascular events
Sakuma K, Hamada K, Yamaguchi A, Aoi W
Exenatide (EXE) (2 mg weekly), Dapagliflozin (DAPA) (10 mg daily), Exenatide + Dapagliflozin (2 mg weekly/10 mg daily), Dapagliflozin (10 mg) + Metformin (MET) (2000 mg extended release daily), or Phentermine (7.5 mg)/Topiramate were given to the patients for 24 weeks (46 mg extended release daily)
Strong pharmacovigilance, physician-led prescribing, patient education, and real-world evidence generation will be critical to sustain long-term trust in this therapeutic class
Secondary BMS is related with post-operation sequelae